Bailey David R 4

What Happened
David R. Bailey, President & CEO and a director of Orthopediatrics Corp. (KIDS), received a grant/award of 119,140 shares on 2026-06-09. The shares were reported as acquired at $0.00 (award/compensatory grant), so the Form 4 shows $0 cash consideration for this transaction. A filing footnote states this includes restricted stock awards totaling 307,031 shares.

Key Details

• Transaction date: 2026-06-09; Filing date: 2026-06-10 (timely filing).
• Transaction type/code: Award/Grant (A). Price: $0.00; reported acquisition value: $0.
• Shares reported in this grant: 119,140. Footnote: "Includes restricted stock awards totaling 307,031 shares."
• Shares owned after the transaction: Not specified in the provided filing details.
• No sale or immediate disposition reported in this filing.

Context
Restricted stock awards are typically compensatory and subject to vesting and restrictions; they are not the same as an open-market purchase and do not necessarily signal the insider's near-term trading sentiment. This Form 4 reports a grant to the CEO rather than a purchase or sale.